Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now official registry

Attention clinical trials

Every US clinical trial registered for Attention — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

14 US clinical trials · 5 currently recruiting

The research picture

Attention has 14 registered US clinical trials, 5 of them open to new participants right now — about 36% of the total.

5
recruiting participants now
36%
of trials open to enrollment
0
in Phase 3–4 (later-stage)
3
top sponsor: Brigham and Women's Hospital

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING NA 422 participants

A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population

Pharmavite

NCT06837246

RECRUITING NA 225 participants

An Investigation of Attentional and Inhibitory Processes During Active Visual Search in Humans

University of Colorado, Denver

NCT06587113

RECRUITING NA 50 participants

Experiment 3: Mixed vs Blocked; Dashboard Paradigm

Brigham and Women's Hospital

NCT06934213

RECRUITING NA 40 participants

Experiment 2: One Target in Many Situations

Brigham and Women's Hospital

NCT06934148

RECRUITING NA 40 participants

Mixed Vs Blocked Search: Four Unique Tasks

Brigham and Women's Hospital

NCT06933693

ACTIVE NOT RECRUITING NA 69 participants

EndeavorOTC® Research Study in College Students

Akili Interactive Labs

NCT06376032

COMPLETED NA 201 participants

Does Increasing Attentional Control Decrease Acute Fear Response

Northern Illinois University

NCT04080115

COMPLETED NA 94 participants

Attention Training

University of Wisconsin, Madison

NCT01518738

COMPLETED NA 28 participants

Mobile Technology Monitoring System to Assess a Web-based Intervention for Teen Risky Driving

University of Pennsylvania

NCT02695888

COMPLETED NA 26 participants

Effects of Cognitive Training on Academic Task Performance in Attention Deficit Hyperactivity Disorder (ADHD)

University of California, Davis

NCT01124721

COMPLETED NA 25 participants

A Study to Assess the Synergistic Effects of a Cranberry Beverage on Cognitive Function

Ocean Spray Cranberries

NCT05008549

COMPLETED 16 participants

Evaluating Multivariate MRI Maps of Body Awareness

University of California, San Francis

NCT03344081

COMPLETED Early Phase 1 12 participants

Effects of Acetylcholine and Attention on Visual Spatial Representations in the Brain

University of California, Berkeley

NCT05003063

COMPLETED NA 10 participants

Probing the Role of Feature Dimension Maps in Visual Cognition: Impact of Salience Level (Expt 1.1)

University of California, Santa Barbara

NCT06175312

Phase Distribution

PhaseTrial count
Phase 1 1

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Attention Trial Landscape

ClinicalTrials.gov lists 14 US studies indexed under Attention, and 5 of those are currently open to recruitment — roughly 36% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Attention shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Attention is led by Brigham and Women's Hospital with 3 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 14 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Attention?

PlainTrial tracks 14 US clinical trials for Attention, of which 5 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Attention?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →